BYETTA is a non-insulin type 2 diabetes injection medication for adults. Important Safety Information for BYETTA (exenatide) injection . with prior severe hypersensitivity reactions to exenatide or to any of the product components. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution for injection in pre-filled pen exenatide. Read all of this leaflet carefully.
|Published (Last):||9 February 2013|
|PDF File Size:||1.5 Mb|
|ePub File Size:||5.15 Mb|
|Price:||Free* [*Free Regsitration Required]|
The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness.
The site you exenatde about to visit is maintained by a third party who is solely responsible for its contents. This product information is intended for US Healthcare Professionals only.
Oral medications dependent on threshold concentrations for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA. BYETTA slows gastric emptying and can reduce the extent and rate of absorption of orally administered drugs.
If pancreatitis is suspected, BYETTA should be discontinued promptly and should not be restarted if pancreatitis is confirmed. AstraZeneca provides this link as a service to website visitors.
Welcome to BYETTA.com!
Postmarketing reports of increased international normalized ratio INR sometimes associated with bleeding with concomitant use of warfarin. Because exenatide is commonly associated with gastrointestinal adverse reactions, BYETTA is not recommended in patients with severe gastrointestinal disease eg gastroparesis. No placebo-treated patients withdrew due to nausea or vomiting.
Talk to your healthcare provider first if you are breastfeeding or plan to breastfeed. Tell your healthcare provider if you have severe problems with your stomach, such as delayed emptying of your stomach gastroparesis or problems with digesting food.
Your risk for getting low blood sugar hypoglycemia is higher if you take BYETTA with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Use with caution with medications that have a narrow therapeutic index or require rapid gastrointestinal absorption.
You are encouraged to report negative side effects of prescription drugs to the FDA. Drug Interactions Oral Medications: Symptoms of a severe allergic reaction include severe rash or itching, swelling of your face, lips, and throat that exdnatide cause difficulty breathing or swallowing, feeling faint or dizzy and very rapid heartbeat.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
The most frequently reported adverse reactions leading to withdrawal for Byetta-treated patients were nausea 5. Not a substitute for insulin and should not be used in patients with type 1 diabetes or diabetic ketoacidosis.
These may be symptoms of pancreatitis. Increased risk of hypoglycemia when used in combination with a sulfonylurea SU or when used with a glucose-independent insulin secretagogues eg, meglitinides.
To report drug exposure during pregnancy call Pen-sharing poses a risk for transmission of blood-borne pathogens, even if the needle is changed. All other trademarks are property of their respective owners.
Official BYETTA® (exenatide) injection Healthcare Professional Website
Use with caution in patients with renal transplantation or when initiating or escalating the dose in patients with moderate renal failure. Use in pediatric patients is not recommended as safety and effectiveness have not been established. Approved Uses BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
You may report side effects related to AstraZeneca products by clicking here. Should not be used in patients with severe renal impairment or end-stage renal disease. Write your html here Go to Patient Site. This site is intended for US Consumers. No clinical studies establishing conclusive evidence of macrovascular risk reduction with BYETTA or any other antidiabetic drug.
Tell your healthcare provider if you have or had kidney problems or a kidney transplant. Postmarketing reports of serious hypersensitivity reactions eg anaphylaxis and angioedema. Exenatidw may develop antibodies to exenatide. If worsening of or failure to achieve adequate glycemic control occurs, consider alternative antidiabetic therapy.
Stop taking BYETTA and call your healthcare pzckage right away if you have pain in your stomach area abdomen that is severe, and will not go away, occurs with or without vomiting or is felt going from your abdomen through to your back. Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth.
Before taking BYETTA, tell your healthcare provider if exenztide have had pancreatitis, stones in your gallbladder gallstonesa history of alcoholism, or high blood triglyceride levels. After initiation and dose increases of BYETTA, observe patients carefully for pancreatitis including persistent severe abdominal pain, sometimes radiating to the back, pakage or without vomiting.
The Double B logo is a trademark of the AstraZeneca group of companies. It is unknown whether patients with a history of pancreatitis are at increased risk for pancreatitis while using BYETTA; consider other antidiabetic therapies for these patients. Staying Active Learn how regular physical activity can help you manage type 2 diabetes.
Go to Healthcare Professional Site. BYETTA should not be used in people with type 1 diabetes or people with diabetic ketoacidosis eexenatide condition caused by very high blood sugar.
Based on animal data, BYETTA may cause fetal harm and should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. Concurrent use with prandial insulin has not been studied and cannot be recommended. BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.